RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 75 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,305,402 | +38.3% | 5,160,541 | -0.5% | 0.02% | +41.2% |
| Q2 2023 | $85,517,354 | -9.7% | 5,186,013 | -2.3% | 0.02% | -15.0% |
| Q1 2023 | $94,742,942 | -37.5% | 5,310,703 | +2.1% | 0.02% | -41.2% |
| Q4 2022 | $151,476,183 | +29.4% | 5,201,792 | +8.9% | 0.03% | +25.9% |
| Q3 2022 | $117,040,000 | +792.3% | 4,777,178 | +51.2% | 0.03% | +800.0% |
| Q2 2022 | $13,116,000 | -65.9% | 3,160,386 | -5.4% | 0.00% | -62.5% |
| Q1 2022 | $38,474,000 | +24.5% | 3,339,750 | +7.9% | 0.01% | +33.3% |
| Q4 2021 | $30,904,000 | -18.6% | 3,096,548 | +6.6% | 0.01% | -25.0% |
| Q3 2021 | $37,943,000 | +81.4% | 2,905,319 | +172.0% | 0.01% | +60.0% |
| Q2 2021 | $20,915,000 | +49.2% | 1,068,211 | +62.1% | 0.01% | +25.0% |
| Q1 2021 | $14,021,000 | +799.9% | 659,154 | +1157.6% | 0.00% | – |
| Q4 2020 | $1,558,000 | +27.8% | 52,412 | -6.9% | 0.00% | – |
| Q3 2020 | $1,219,000 | +65.2% | 56,268 | +70.1% | 0.00% | – |
| Q2 2020 | $738,000 | -6.6% | 33,073 | -36.3% | 0.00% | – |
| Q1 2020 | $790,000 | -46.9% | 51,914 | -19.9% | 0.00% | – |
| Q4 2019 | $1,489,000 | +32.9% | 64,841 | +25.0% | 0.00% | – |
| Q3 2019 | $1,120,000 | -8.9% | 51,892 | -7.1% | 0.00% | – |
| Q2 2019 | $1,229,000 | -4.5% | 55,844 | +18.9% | 0.00% | – |
| Q1 2019 | $1,287,000 | +139.2% | 46,966 | +134.5% | 0.00% | – |
| Q4 2018 | $538,000 | +76.4% | 20,031 | +91.3% | 0.00% | – |
| Q3 2018 | $305,000 | +29.8% | 10,470 | +39.3% | 0.00% | – |
| Q2 2018 | $235,000 | – | 7,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |